Analytical and biomedical applications of microfluidics in traditional Chinese medicine research

Traditional Chinese medicine (TCM) has significant benefits in the prevention and treatment of diseases due to its unique theoretical system and research techniques. However, there are still key issues to be resolved in the full interpretation and use of TCM, such as vague active compounds and mechanism of action. Therefore, it is promising to promote the research on TCM through innovative strategies and advanced cutting-edge technologies. Microfluidic chips have provided controllable unique platforms for biomedical applications in TCM research with flexible composition and large-scale integration. In this review, the analysis and biomedical applications of microfluidics in the field of TCM are highlighted, including quality control of Chinese herbal medicines (CHMs), delivery of CHMs, evaluation of pharmacological activity as well as disease diagnosis. Finally, potential challenges and prospects of existing microfluidic technologies in the inheritance and innovation of TCM are discussed.Copyright © 2022 Elsevier B.V.

Research progress in pathogen spectrum of hand，foot，and mouth disease and the potential impact of licensed EV71 vaccines in China

Vaccination is globally recognized as the most economical and effective tool in public health. Between December 2015 and May 2017, three vaccines against EV71 (including the EV71 human diploid cell vaccine developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences, the inactivated EV71 vaccine developed by Sinovac Biotech Ltd. and the inactivated EV71 vaccine developed by Wuhan Institute of Biological Products Co. Ltd.) have been licensed by CFDA in China. As a preventive measure to control HFMD, how effective they are and what impact they have on the epidemic of HFMD are of great concern in the industry. The prevalence of HFMD in China has obvious seasonality, and the most common causative strains are EV71 and Coxsackievirus A16 (Cox A16). In order to provide a scientific basis for the prevention and control of HFMD, this paper summarizes the immune objects, immune procedures, immunogenicity, immune effect and cross immunization of the above three EV71 vaccines, and the etiological changes of mild, severe and death cases after the three vaccines have been released on the market. © 2022 The authors.

Predictors for fear of cancer recurrencein breast cancer patients referred for radiation therapyduring the COVID-19 pandemic: A multi-center cross-section survey

Background The outbreak of COVID-19 pandemic in China has greatly impacted the radiotherapy (RT) strategy forbreast cancer (BC) patients, which might lead to an increased distressing psychological symptom. Thus, we performa multi-center cross-section survey aiming to investigate the prevalence of fears of cancer recurrence (FCR) andexplore predictors for FCR in BC patients referred for RT during pandemic. Methods: 542 BC patients who referredfor RT between 24 Jan and 30 April 2020 during pandemic were consecutively enrolled from 14 hospitals aroundChina including Yangtze Delta River Region, Guangdong and Shanxi province. Patients' sociodemographic,treatment information as well as psychological characteristics were collected using an information sheet, Fear ofprogression questionnaire-short form (FoP-Q-SF), Hospital Anxiety and Depression Scale ( HADS) and EORTCQLQ-C30. The influence of pandemic on RT schedule was divided into four categories: “delay” was defined as >12weeks from surgery to RT in patients without chemotherapy or >8 weeks from last time of anti-tumor therapy(including chemotherapy and surgery) to RT in patients with chemotherapy;“Special normal” was defined thatpatients themselves believed to have delayed RT initiation but actually not;“Interruption” was defined as anyunplanned gaps in original RT regime and all other would be classified into “normal”. Another type of influence on th th Advertisement RT strategy was that patients had to shift planned RT hospital from Grade-A tertiary hospital to local hospitals.Univariable analyses of FCR were performed in a one-way analysis of variance (ANOVA) or student t-test orPearson correlation analyses and candidate variables with P<0.2 were included Hierarchical multiple regressionmodels to investigate predictors for FCR. Guangdong province was chosen as reference in models. Results 488patients with complete data were eligible for the present analysis and none of patients and their family members hadbeen diagnosed as COVID-19. The RT strategy was affected in 265 (54.3%) patients, including 143 with delayed RTinitiation, 66 with “special normal” schedule, 24 (4.9%) with RT interruptions, 19 shifting to local hospitals for RT, andthe remaining 13 being influenced on both RT schedule and planned RT hospitals. Most of patients with affected RTstrategy occurred in late January and February, when was peak of COVID-19 pandemic in China. The mean FCRscores was 24.83 (SD=8.554) and 84 patients (17.3%) were classified as dysfunctional level of FCR (sum score≥34). In univariable analyses, FCR were significantly higher in patients who received RT in Guangdong provinceand in hospitals with < 100 BC cases per year. In term of during pandemic, a significant difference in FCR wasobserved in terms of influence on RT schedule (p<0.001). and changes of hospital levels(p=0.009). There weresignificant correlations between FCR and anxiety/depressive in HADS or all five function scales (physical, role,emotional, cognitive and social) and global QoL in QLQ-C30 (p<0.001). Finally, the model explained 59.7% ofobserved variances in FCR and showed that influence of RT strategy during pandemic had significantly impacted onFCR (ΔR2=0.01, ΔF=2.966, p=0.019). Hospitals in Shanxi province (β=-0.117, p=0.001), emotional function(β=-0.19, p<0.001), social function (β=-0.111, p=0.006), anxiety (β=0.434, p<0.001) and RT interruption (β=0.071,p=0.035) were independent predictors for FCR. Conclusions RT strategy for BC patients was greatly influencedduring pandemic. RT interruption is an independent predictor for high FCR. Our findings emphasize the necessity toensure the continuum of RT in BC patients, and efforts should be taken to alleviate the FCR through psychologicalinterventions.

[Epidemiological characteristics of COVID-19 monitoring cases in Yinzhou district based on health big data platform].

Objective: To understand the epidemiological characteristics of COVID-19 monitoring cases in Yinzhou district based on health big data platform to provide evidence for the construction of COVID-19 monitoring system. Methods: Data on Yinzhou COVID-19 daily surveillance were collected. Information on patients' population classification, epidemiological history, COVID-19 nucleic acid detection rate, positive detection rate and confirmed cases monitoring detection rate were analyzed. Results: Among the 1 595 COVID-19 monitoring cases, 79.94% were community population and 20.06% were key population. The verification rate of monitoring cases was 100.00%. The total percentage of epidemiological history related to Wuhan city or Hubei province was 6.27% in total, and was 2.12% in community population and 22.81% in key population (P<0.001). The total COVID-19 nucleic acid detection rate was 18.24% (291/1 595), and 53.00% in those with epidemiological history and 15.92% in those without (P<0.001).The total positive detection rate was 1.72% (5/291) and the confirmed cases monitoring detection rate was 0.31% (5/1 595). The time interval from the first visit to the first nucleic acid detection of the confirmed monitoring cases and other confirmed cases was statistically insignificant (P>0.05). Conclusions: The monitoring system of COVID-19 based on the health big data platform was working well but the confirmed cases monitoring detection rate need to be improved.

[Application of healthcare big data in active case finding of COVID-19 in Yinzhou district of Ningbo].

During the prevention and control of the COVID-19 epidemic, identifying and controlling the source of infection has become one of the most important prevention and control measures to curb the epidemic in the absence of vaccines and specific therapeutic drugs. While actively taking traditional and comprehensive "early detection" measures, Yinzhou district implemented inter-departmental data sharing through the joint prevention and control mechanism. Relying on a healthcare big data platform that integrates the data from medical, disease control and non-health sectors, Yinzhou district innovatively explored the big data-driven COVID-19 case finding pattern with online suspected case screening and offline verification and disposal. Such effort has laid a solid foundation and gathered experience to conduct the dynamic and continuous surveillance and early warning for infectious disease outbreaks more effectively and efficiently in the future. This article introduces the exploration of this pattern in Yinzhou district and discusses the role of big data-driven disease surveillance in the prevention and control of infectious diseases.